Science and Enterprise

Tag: pharmaceuticals

  • Cambridge, GSK to Develop Therapies for Lung/Liver Disorder

    University of Cambridge in the U.K. will partner with the global pharmaceutical company GlaxoSmithKline to discover and develop new medicines to treat a genetic disease affecting the lungs and liver. The university is expected to receive an upfront payment, and is eligible for milestone payments and royalties under the agreement, but the amounts of those…

  • Report: U.S. Health Care Needs to Adopt Learning Culture

    A new report by the Institute of Medicine (IOM), part of the National Academies of Science, says the U.S. health care system pays too much for outcomes that fall short on quality, but can learn from other industries to continuously improve the quality of care at lower cost. The committee that prepared the report for…

  • Early-Stage Biomedical Accelerator Gains $21M Initial Funding

    BioMotiv, a Cleveland company supporting early-stage medical research for commercial development into therapies, secured $21 million in its first financing round. The funds are being provided by BioMotiv’s founding investors, University Hospitals health care system in northeast Ohio and the Harrington Family of Hudson, Ohio, a supporter of translational biomedical research. The company provides financing…

  • Pharma Company Allergan to Build New Jersey R&D Center

    Allergan Inc., a developer of specialty pharmaceutical products, will build a new research and development center in Bridgewater, New Jersey. According to a company announcement, the the 93,000-square-foot facility is expected to employ “several hundred” employees, but neither the precise number nor types of the jobs were disclosed. Allergan, headquartered in Irvine, California, develops and…

  • RNA Nanoparticles Advanced for Cancer Drug Delivery

    Medical researchers at University of Kentucky and University of Nebraska developed nanoscale particles using RNA to deliver cancer drugs that could bind to and regulate cells in mice without harming other tissue. The results of the research carried out in the the lab of Kentucky’s Peixuan Guo (pictured right) appear in the August issue of…

  • Stem Cell Therapy Results Reported for Spinal Cord Injury

    Researchers for StemCells Inc. in Newark, California reported interim, largely positive, results from a clinical trial of stem cell therapy to treat spinal cord injury. The findings were reported yesterday at a meeting of the International Spinal Cord Society in London. The trial tests StemCells’ therapy to treat disorders of the central nervous system, called…

  • Biopharma Start-Up Secures $27 Million in Venture Funding

    Aerpio Therapeutics, a biopharmaceutical company in Cincinnati, closed a $27 million series A financing deal, the first round of funding after initial start-up. The round was led by Novartis BioVentures with Venture Investors LLC, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners, and AgeChem Venture Fund. The company began in January 2012 as a…

  • University to Develop, Commercialize HIV/AIDS Nanomedicines

    Researchers at University of Liverpool in the U.K. are developing nanoscale therapies to treat HIV and AIDS, and collaborating with a company to take the drugs to market. The project is funded by a £1.65 million ($US 2.61 million) grant from the U.K.’s Engineering and Physical Sciences Research Council. The aim of the project is…

  • Janssen Licenses Biotech’s Antibody for Multiple Myeloma

    Janssen Pharmaceutical Companies, a division of Johnson & Johnson in Horsham, Pennsylvania, agreed to license a cancer drug targeting multiple myeloma made by biotechnology company Genmab A/S in Copenhagen, Denmark. The agreement has a total potential value of $1.1 billion from upfront, milestone, and royalty payments, as well as an equity investment in Genmab. The…

  • New Process Simplifies Protein Production for Drug Companies

    A chemical engineer at University of Arkansas in Fayetteville developed a new method for producing high quality proteins used in drugs for treating an assortment of disorders. Doctoral candidate Ellen Brune (pictured right) also founded a company, Boston Mountain Biotech, to commercialize the technology. Current industry methods for protein manufacturing require separating out the background…